Fresh guidance provided by Ansell at its AGM implies a 40/60 skew in earnings to the second half compared to a 45/55 average over FY15-19. Macquarie sees price as a more relative factor in the 2H and on current dynamics, retains Sell.The broker had previously highlighted the benefit of price increases over and above dollar cost pass-through, primarily for examination and single-use products, based on recent trends now sees downside risk to FY22 guidance and consensus expectations.Target falls to $30.70 from $32.00.Sector: Health Care Equipment & Services. Target price is $30.70.Current Price is $30.52. Difference: $0.18 – (brackets indicate current price is over target). If ANN meets the Macquarie target it will return approximately 1% (excluding dividends, fees and charges – negative figures indicate an expected loss).
- Forums
- ASX - By Stock
- Ann: Ansell Limited FY22 Trading and Business Update
Fresh guidance provided by Ansell at its AGM implies a 40/60...
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ANN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$24.74 |
Change
-0.300(1.20%) |
Mkt cap ! $3.528B |
Open | High | Low | Value | Volume |
$25.16 | $25.17 | $24.70 | $5.345M | 215.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1108 | $24.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$24.82 | 1709 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1108 | 24.680 |
1 | 1 | 24.670 |
3 | 1709 | 24.660 |
1 | 1108 | 24.630 |
2 | 1358 | 24.610 |
Price($) | Vol. | No. |
---|---|---|
24.820 | 1709 | 5 |
24.850 | 1108 | 1 |
24.870 | 1108 | 1 |
24.900 | 1108 | 1 |
25.000 | 450 | 1 |
Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
Last
$24.70 |
  |
Change
-0.300 ( 1.72 %) |
|||
Open | High | Low | Volume | ||
$25.12 | $25.12 | $24.70 | 146372 | ||
Last updated 15.59pm 03/05/2024 ? |
Featured News
ANN (ASX) Chart |